The Society for Immunotherapy of Cancer (SITC) 28th Annual Meeting: Workshop on Personalized Cancer ImmunotherapyNovember 7, 2013 Gaylord National Hotel & Convention Center National Harbor, MDProgram OrganizersWillem W. Overwijk, PhD - MD Anderson Cancer Center Hans-Georg Rammensee, PhD - Universitaet Tuebingen Nicholas P. Restifo, MD - National Cancer Institute Ena Wang, MD - National Institutes of Health, CC, DTMProgram SummaryThe purpose of this Workshop was to bring participants up to date on the latest in patient-specific genomic and molecular analysis, and the application of this information in personalized immunotherapy of cancer. Technologies include genome-wide DNA and RNA sequencing, epigenetic regulation and transcript variation, identification of mutations, polymorphisms associated with cancer risk and clinical outcome, patient-specific T cell epitope discovery, and immunophenotyping. Applications include choosing the “right” antigen, induction of therapeutic immunity, blocking of immune checkpoints such as CTLA-4 and PD-1, combinations of immunotherapy with targeted therapy, and patient-specific immune monitoring. By participating in this Workshop, participants interacted with international leaders in the field of personalized immunotherapy to learn about the latest technologies, current applications, critical unaddressed questions, and future directions. Most importantly, participants had the opportunity to build connections and collaborations to spark new discoveries, interventions and applications.Target AudienceThe target audience for this program includes basic scientists and clinical investigators from academic institutions, industry, and regulatory agencies. The audience includes clinicians, translational and basic researchers, graduate students, and postdoctoral fellows involved in cancer research.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org